Compare Bath & Body Works Inc (BBWI) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Lemonade Inc — how do they compare? Bath & Body Works Inc trades at $18.16 (market cap $3.81B), while Lemonade Inc trades at $51.65 (market cap $4.09B). The key difference: Bath & Body Works Inc and Lemonade Inc are close in size by market cap, and Bath & Body Works Inc pays a 4.24% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals.
| BBWI | LMND | |
|---|---|---|
Market Cap | $3.81B | $4.09B |
Sector | Consumer Cyclical | Financials |
52-Week High | $31.87 | $96.57 |
52-Week Low | $14.85 | $47.38 |
Enterprise Value | $7.70B | $3.95B |
Dividend Yield | 4.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $18.28, down 5.38% over 24 hours, with a bearish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 5.36 and P/S of 0.54, while maintaining strong gross margins above 43%. Recent earnings have mostly beaten expectations, and the company is expanding internationally through partnerships with Ulta Beauty and entry into Brazil. Cash flow trends show improvement, with positive net cash flow projected for 2026.
The investment case hinges on BBWI's deep value proposition against declining revenue trends. Key opportunities include international growth and strategic partnerships, while risks involve high debt levels and ongoing revenue pressure. Analyst consensus is mixed with a $22.11 price target suggesting upside potential from current levels.
Lemonade (LMND) trades at $51.63, down 1.99% on the day, with a bearish technical signal from moving averages. Revenue growth is strong, reaching $737.9M in 2025, but the company remains unprofitable with a net income margin of -14.19%. Recent Q2 2026 earnings beat expectations, and the company targets positive adjusted EBITDA by Q4 2026, yet the stock faces selling pressure amid valuation concerns.
The outlook hinges on Lemonade's path to profitability; achieving its EBITDA target could drive upside toward the $58 consensus price target. Key risks include persistent losses, competitive pressures, and execution challenges in scaling its AI-driven insurance model. Investor sentiment is divided, reflecting the high-growth but high-burn profile.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
